Skip to main content
MUSTANG BIO, INC. logo

MUSTANG BIO, INC. — Investor Relations & Filings

Ticker · MBIO ISIN · US62818Q1040 LEI · 5493004W0VC1DPECQ779 US Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2022-06-08 Director's Dealing
Country US United States of America
Listing US MBIO

About MUSTANG BIO, INC.

https://www.mustangbio.com/

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cell and gene therapies. The company's primary focus is on translating medical breakthroughs into potential cures for difficult-to-treat cancers and rare genetic diseases. Its pipeline is centered on Chimeric Antigen Receptor (CAR) T-cell therapies, a form of immunotherapy. Mustang Bio's strategy involves in-licensing promising technologies from academic institutions and advancing them through clinical trials, supported by its in-house manufacturing capabilities to ensure the production and delivery of these advanced treatments.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2022-06-08 English
8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 24, 2022, by Mustang Bio, Inc. The content focuses on a notice from Nasdaq regarding the company's non-compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. It details the grace period allowed to regain compliance and the potential consequences including delisting. This is a regulatory announcement about the company's listing status rather than a financial report or earnings release. The key section is titled 'Item 3.01 Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,' which clearly indicates it is a delisting announcement. Therefore, the appropriate classification is Delisting Announcement (DLST). The document length and content confirm it is not merely an announcement of a report but the actual notice itself, supporting high confidence.
2022-05-31 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 12, 2022, by Mustang Bio, Inc. It announces the issuance of a press release providing a corporate update and announcing financial results for the first quarter ended March 31, 2022. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The length is 3063 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of financial results, not the full earnings release or quarterly report itself. Therefore, the appropriate classification is Earnings Release (ER), as it is the initial announcement of quarterly financial results.
2022-05-12 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-12 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically titled as "Definitive Additional Materials" related to the company's Annual Meeting. It includes voting items such as election of directors, ratification of auditors, and amendments to corporate documents. This type of filing is used to solicit shareholder votes and provide information about proposals to be voted on at the Annual General Meeting. The document is not the Annual Report itself, nor is it a report publication announcement. It is a Proxy Solicitation & Information Statement as it provides materials sent to shareholders to inform and request votes for the meeting.
2022-04-29 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.